Heterocyclic compounds and their pharmaceutical formulation

Details Heterocyclic compounds and their pharmaceutical formulation Heterocyclic compounds and their pharmaceutical formulation

1988-11-04

1992-02-25

Fan, Jane T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546321, C07D21186, A61K 31455

Patent

active

050913956

ABSTRACT:
Compounds are described of the formula ##STR1## wherein R.sub.1 and R.sub.4 independently represent a C.sub.1-4 alkyl group;

REFERENCES:
patent: 3923818 (1975-12-01), Bossert et al.
patent: 4145432 (1979-03-01), Sato
patent: 4307103 (1981-12-01), Sato et al.
patent: 4430333 (1984-02-01), Campbell et al.
patent: 4492703 (1985-01-01), Goldmann et al.
patent: 4801599 (1989-01-01), Semeraro et al.
Ca 93:204462g. Teraji et al.
Rahwan et al., Annual Reports in Medicinal Chemistry 1981, pp. 257-264.
Thomas, G. et al., J. Cardiovascular Pharm. 6, pp. 1170-1176, (1984).

Affiliated with

Also associated with

Rating

Heterocyclic compounds and their pharmaceutical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic compounds and their pharmaceutical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds and their pharmaceutical formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1893168